# Ablative Stereotactic MR-Guided Adaptive Reirradiation

> **NCT06397573** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Baptist Health South Florida** · enrollment: 10 (estimated)

## Conditions studied

- Abdominal Cancer
- Pelvic Cancer

## Interventions

- **RADIATION:** Reirradiation

## Key facts

- **NCT ID:** NCT06397573
- **Lead sponsor:** Baptist Health South Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-06-05
- **Primary completion:** 2026-08
- **Final completion:** 2027-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06397573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06397573, "Ablative Stereotactic MR-Guided Adaptive Reirradiation". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06397573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*